Mingus
Well-known member
http://www.ingentaconnect.com/conte...41333c4a2f243838762c3167662377675fdd3618a5d43
Monitoring Vaccine Safety During an Influenza Pandemic
Authors: Iskander, John<sup>1</sup>; Haber, Penina<sup>1</sup>; Herrera, Guillermo<sup>1</sup>
Source: The Yale Journal of Biology and Medicine, Volume 78, Number 5, October 2005, pp. 265-275(11)
Publisher: Yale Journal of Biology and Medicine
<form method="post" action="/marked-list;jsessionid=2bqm0anqat3hi.victoria" id="markedListForm" name="markedListForm"> <input name="pageSize" value="" type="hidden"> <input name="page" value="" type="hidden"> <input name="sortOrder" value="" type="hidden"> <input name="redirectTo" value="/content/yjbm/jobm/2005/00000078/00000005/art00005?token=004e113b66b3427656c3c6a333f25663541333c4a2f243838762c3167662377675fdd3618a5d43" type="hidden"> <input name="art0" value="infobike://yjbm/jobm/2005/00000078/00000005/art00005" type="hidden"> <input src="http://a465.g.akamai.net/f/465/1984/1d/www.ingentaconnect.com/images/mark_item.gif" alt="Add article to your marked list" type="image">
</form>
Key:
- Free content
- New Content
- Subscribed Content
- Free Trial Content
<script language="JavaScript"> CM8ShowAd("Skyscraper"); </script>
Abstract:
In the event that a vaccine is available during an influenza pandemic, vaccine safety monitoring will occur as part of comprehensive public health surveillance of the vaccination campaign. Though inactivated influenza vaccines have been widely used in the United States and much is known about their safety profile, attention will need to be paid to both common self-limited adverse reactions and rarer, more serious events that may or may not be causally related to vaccination. The primary surveillance systems used to generate and test hypotheses about vaccine safety concerns are the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD), respectively. Examples of recent use of these systems to investigate influenza vaccine safety and enhancements planned for use during a pandemic are presented. Ethical issues that will need to be addressed as part of an overall vaccine safety response include risk communication and injury compensation. Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic.
<form name="refData" method="get" action="#"> References: 50 references <input name="supWin" onclick="javascript:if ( document.refData.supWin.checked ) popup('/content/yjbm/jobm/2005/00000078/00000005/art00005/references;jsessionid=2bqm0anqat3hi.victoria?view=popup','supWin','780','600')" type="checkbox"> open in new window
</form> <noscript> Opening the references page in a new window requires javascript to be enabled in your browser.
</noscript> Articles that cite this article?
Document Type: Short communication
Affiliations: 1: Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta Georgia
The full text article is available for purchase
$18.00
Monitoring Vaccine Safety During an Influenza Pandemic
Authors: Iskander, John<sup>1</sup>; Haber, Penina<sup>1</sup>; Herrera, Guillermo<sup>1</sup>
Source: The Yale Journal of Biology and Medicine, Volume 78, Number 5, October 2005, pp. 265-275(11)
Publisher: Yale Journal of Biology and Medicine
<form method="post" action="/marked-list;jsessionid=2bqm0anqat3hi.victoria" id="markedListForm" name="markedListForm"> <input name="pageSize" value="" type="hidden"> <input name="page" value="" type="hidden"> <input name="sortOrder" value="" type="hidden"> <input name="redirectTo" value="/content/yjbm/jobm/2005/00000078/00000005/art00005?token=004e113b66b3427656c3c6a333f25663541333c4a2f243838762c3167662377675fdd3618a5d43" type="hidden"> <input name="art0" value="infobike://yjbm/jobm/2005/00000078/00000005/art00005" type="hidden"> <input src="http://a465.g.akamai.net/f/465/1984/1d/www.ingentaconnect.com/images/mark_item.gif" alt="Add article to your marked list" type="image">
</form>
Key:
<script language="JavaScript"> CM8ShowAd("Skyscraper"); </script>
Abstract:
In the event that a vaccine is available during an influenza pandemic, vaccine safety monitoring will occur as part of comprehensive public health surveillance of the vaccination campaign. Though inactivated influenza vaccines have been widely used in the United States and much is known about their safety profile, attention will need to be paid to both common self-limited adverse reactions and rarer, more serious events that may or may not be causally related to vaccination. The primary surveillance systems used to generate and test hypotheses about vaccine safety concerns are the Vaccine Adverse Event Reporting System (VAERS) and the Vaccine Safety Datalink (VSD), respectively. Examples of recent use of these systems to investigate influenza vaccine safety and enhancements planned for use during a pandemic are presented. Ethical issues that will need to be addressed as part of an overall vaccine safety response include risk communication and injury compensation. Advance planning and the use of available technologic solutions are needed to respond to the scientific and logistic challenges involved in safely implementing mass vaccination during a pandemic.
<form name="refData" method="get" action="#"> References: 50 references <input name="supWin" onclick="javascript:if ( document.refData.supWin.checked ) popup('/content/yjbm/jobm/2005/00000078/00000005/art00005/references;jsessionid=2bqm0anqat3hi.victoria?view=popup','supWin','780','600')" type="checkbox"> open in new window
</form> <noscript> Opening the references page in a new window requires javascript to be enabled in your browser.
</noscript> Articles that cite this article?
Document Type: Short communication
Affiliations: 1: Immunization Safety Office, Office of the Chief Science Officer, Office of the Director, Centers for Disease Control and Prevention, Atlanta Georgia
The full text article is available for purchase
$18.00